Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 2:28 PM
Ignite Modification Date:
2025-12-24 @ 2:28 PM
NCT ID:
NCT03069859
Eligibility Criteria:
Inclusion Criteria:
* 18 years of age or older
* Singleton pregnancy
* Confirmed pregnancy
* Gestational age \>32\^0/7 weeks
Exclusion Criteria:
* Lack of patient consent
* Multiple pregnancy
* History of eclampsia or preeclampsia in current pregnancy
* Imminent Delivery as suspected by any RN or MD involved in delivery care
* History of cardiovascular complications:
* Coronary artery disease or myocardial infarction
* Repaired or unrepaired congenital heart disease
* Vascular disease(s)
* Severe unstable arrhythmia (e.g. Rapid atrial fibrillation, paroxysmal fibrillation, atrial flutter, etc.)
* Congestive heart failure
* Contraindication to TXA:
* History of venous thromboembolism
* Active thromboembolic disease
* High risk of thrombosis (e.g. Factor V Leiden or Protein C deficiency)
* Acquired disturbances of colour vision
* Allergy to TXA
* History of seizure disorder
* Pre-existing hematuria
* History of renal insufficiency
* Unlikely to comply with follow-up (e.g. no fixed address, plans to move out of town)
* Prisoner status
Healthy Volunteers:
False
Sex:
FEMALE
Minimum Age:
18 Years
Study:
NCT03069859
Study Brief:
Protocol Section:
NCT03069859